EBiSC

EBiSC

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Edelweiss Connect (3 weeks ago)
TEAM mastery s.r.l. joins #SaferWorldbyDesign collaboration #chemicals #regulatory #invitro #insilico… https://t.co/rwngG0rsps
Edelweiss Connect (4 weeks ago)
#SaferWorldbyDesign presents Case studies advancing skin safety assessment according to OECD guidelines… https://t.co/3WenFwakq3
Edelweiss Connect (5 weeks ago)
Here we present part 1 of our #SaferWorldbyDesign series: Working days of a cosmetic safety assessor in the EU You… https://t.co/a4NMiPcyQP
Edelweiss Connect (5 weeks ago)
Integration of Knowledge Graphs in Trusted FAIR Knowledge Infrastructure #knowledgemanagement #knowledgegraphs… https://t.co/3mUx129kGV
Edelweiss Connect (3 months ago)
#SaferWorldbyDesign Webinar: Case Studies advancing skin safety assessment according to OECD guidelines Within the… https://t.co/uq9zxpGpGR

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA